[go: up one dir, main page]

FI903752A7 - Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi - Google Patents

Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI903752A7
FI903752A7 FI903752A FI903752A FI903752A7 FI 903752 A7 FI903752 A7 FI 903752A7 FI 903752 A FI903752 A FI 903752A FI 903752 A FI903752 A FI 903752A FI 903752 A7 FI903752 A7 FI 903752A7
Authority
FI
Finland
Prior art keywords
acridinamine
tetrahydro
derivatives
preparation
acridinamine derivatives
Prior art date
Application number
FI903752A
Other languages
English (en)
Swedish (sv)
Other versions
FI903752A0 (fi
Inventor
Colin Granger
Jeffrey Alan Kester
Anthony Jerome Thomas
Walter Hamilton Moos
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI903752A0 publication Critical patent/FI903752A0/fi
Publication of FI903752A7 publication Critical patent/FI903752A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Water Treatment By Electricity Or Magnetism (AREA)
FI903752A 1989-07-31 1990-07-27 Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi FI903752A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/387,722 US4999430A (en) 1989-07-31 1989-07-31 Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Publications (2)

Publication Number Publication Date
FI903752A0 FI903752A0 (fi) 1990-07-27
FI903752A7 true FI903752A7 (fi) 1991-02-01

Family

ID=23531113

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903752A FI903752A7 (fi) 1989-07-31 1990-07-27 Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US4999430A (fi)
EP (2) EP0411534B1 (fi)
JP (1) JP2930245B2 (fi)
KR (1) KR910002802A (fi)
AT (2) ATE186908T1 (fi)
AU (1) AU5994590A (fi)
CA (1) CA2022297C (fi)
DE (2) DE69033369T2 (fi)
DK (2) DK0628548T3 (fi)
ES (2) ES2068955T3 (fi)
FI (1) FI903752A7 (fi)
GR (1) GR3032539T3 (fi)
IE (1) IE66823B1 (fi)
NO (1) NO903359L (fi)
NZ (1) NZ234672A (fi)
PT (1) PT94849A (fi)
ZA (1) ZA905978B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85741A (en) * 1987-03-17 1996-05-14 Hoechst Roussel Pharma Substituted tetrahydroacridines a process for their preparation and pharmaceutical compositions containing substituted alpha-amino-tetrahydroacridines
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
US5179100A (en) * 1992-03-09 1993-01-12 Hoechst-Roussel Pharmaceuticals Inc. 4,5-dihydropyrazolo[3,4-a]acridines
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
HU213107B (en) * 1994-02-23 1997-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing acetic acid derivatives and pharmaceutical compositions containing them
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
JPWO2006004201A1 (ja) * 2004-07-01 2008-04-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 神経再生促進剤
CN1315810C (zh) * 2004-08-30 2007-05-16 北京理工大学 哌嗪桥联他克林双体衍生物及其合成方法
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
BR112012014022A2 (pt) * 2009-12-11 2017-04-04 Genecode As composto, composição, dispositivo médico e método ex vivo para modulação do crescimento de um neurônico
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
WO2014144801A1 (en) 2013-03-15 2014-09-18 Agenebio Inc. Methods and compositions for improving cognitive function
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
DK0411534T3 (da) 1995-07-24
NO903359D0 (no) 1990-07-30
IE902751A1 (en) 1991-02-27
DK0628548T3 (da) 2000-05-08
JP2930245B2 (ja) 1999-08-03
GR3032539T3 (en) 2000-05-31
IE66823B1 (en) 1996-02-07
ATE119885T1 (de) 1995-04-15
DE69033369T2 (de) 2000-05-11
EP0411534A3 (en) 1991-06-05
ZA905978B (en) 1992-04-29
EP0411534A2 (en) 1991-02-06
NZ234672A (en) 1991-11-26
DE69017789D1 (de) 1995-04-20
US4999430A (en) 1991-03-12
FI903752A0 (fi) 1990-07-27
CA2022297A1 (en) 1991-02-01
DE69017789T2 (de) 1995-07-13
DE69033369D1 (de) 1999-12-30
ES2141787T3 (es) 2000-04-01
JPH0366670A (ja) 1991-03-22
KR910002802A (ko) 1991-02-26
PT94849A (pt) 1991-04-18
NO903359L (no) 1991-02-01
ATE186908T1 (de) 1999-12-15
EP0628548A1 (en) 1994-12-14
CA2022297C (en) 2001-09-18
EP0411534B1 (en) 1995-03-15
AU5994590A (en) 1991-01-31
ES2068955T3 (es) 1995-05-01
EP0628548B1 (en) 1999-11-24

Similar Documents

Publication Publication Date Title
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI894546A7 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
FI911080A7 (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
FI882165A7 (fi) Menetelmä 4-amino-androsteenidioni-johdannaisten valmistamiseksi.
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI884461A7 (fi) Menetelmä trans-1,1,2-trifenyylibut-1-eenijohdannaisten valmistamiseksi
FI891111A7 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
FI930237A7 (fi) Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FI905992L (fi) Menetelmä metyleeni-pristinamysiini-IA- tai metyleeni-virginiamysiinijohdannaisten valmistamiseksi
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
FI913656A7 (fi) Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi
FI902157A7 (fi) Menetelmä 1,6-hekseenidiohappojen valmistamiseksi
FI92393B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY